R&D-Driven Biopharmaceutical Leader

Takeda Completes Acquisition of Shire, Becoming a Global, Values-based, R&D-Driven Biopharmaceutical Leader
January 10, 2019
Business

Takeda Completes Acquisition of Shire, Becoming a Global, Values-based, R&D-Driven Biopharmaceutical Leader

Takeda Pharmaceutical Company Limited (TSE: 4502) (NYSE: TAK) (“Takeda”) today announced the completion of its acquisition of Shire plc (“Shire”), becoming a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan.   Takeda now has an attractive, expanded geographic footprint and...

107
0
Like
2 months ago
Do NOT follow this link or you will be banned from the site!